dr. (Ken) W.K. Redekop

Associate Professor Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
Erasmus University Rotterdam
J 8-37
+31 10 4088535

Latest academic publication

T.A. Kanters, W.K. Redekop & L. Hakkaart (2018). International differences in patient access to ultra-orphan drugs. Health Policy and Technology, 7, 57-64. doi: https://doi.org/10.1016/j.hlpt.2017.12.001

More information

Back to overview

Ken Redekop, Ph.D. is an associate professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature. Current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice. Most studies relate to diabetes, cardiovascular disease, and cancer, and most involve modelling and evidence synthesis.


Visiting address

Burg. Oudlaan 50 3062 PA Rotterdam

Postal address

Postbus 1738 3000 DR Rotterdam